Miravant Medical Technologies Inc.

MRVT · OTC
Analyze with AI
12/31/2004
12/31/2003
12/31/2002
12/31/2001
Operating Activities
Net Income-$15,896-$7,465-$15,960-$16,402
Dep. & Amort.$346$846$1,702$1,757
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$69$241$3,820-$4,559
Other Non-Cash$4,091-$4,450$1,868$3,957
Operating Cash Flow-$11,528-$10,828-$8,570-$15,247
Investing Activities
PP&E Inv.$0-$306$0-$287
Net Acquisitions$0$0$0$863
Inv. Purchases-$2,987$0-$28,679-$43,684
Inv. Sales/Matur.$0$1,589$33,333$57,930
Other Inv. Act.-$317$28-$83$796
Investing Cash Flow-$3,304$1,311$4,571$14,755
Financing Activities
Debt Repay.$2,000$10,167$1,000$15
Stock Issued$2,129$8$2,419$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$12,785-$351-$155$0
Financing Cash Flow$16,914$9,824$3,264$15
Forex Effect$0$0$0$0
Net Chg. in Cash$2,082$307-$735-$477
Supplemental Information
Beg. Cash$1,030$723$1,458$1,935
End Cash$3,112$1,030$723$1,458
Free Cash Flow-$11,528-$11,134-$8,570-$15,534